Breast cancer and hormone-replacement therapy: the Million Women Study - Reply

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply

Bibliografske podrobnosti
Main Authors:	Beral, V, Banks, E, Reeves, G, Bull, D, Collaborators, MWS
Format:	Journal article
Izdano:	2003

Podobne knjige/članki

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.
od: Banks, E, et al.
Izdano: (2004)

Endometrial cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V, et al.
Izdano: (2005)

Breast cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V
Izdano: (2003)

Ovarian cancer and hormone replacement therapy in the Million Women Study.
od: Beral, V, et al.
Izdano: (2007)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct (multiple letters)
od: Banks, E, et al.
Izdano: (2004)

Ovarian cancer and hormone replacement therapy - Reply
od: Beral, V, et al.
Izdano: (2007)

The characteristics of invasive breast cancer in women who use and do not use hormone replacement therapy in the million women study.
od: Gathani, T, et al.
Izdano: (2006)

Breast cancer and hormone-replacement therapy: the Million Women Study.
od: Bliss, J, et al.
Izdano: (2003)

Characteristics of women who undergo breast reconstruction following mastectomy for breast cancer in the Million Women Study
od: Gathani, T, et al.
Izdano: (2014)

Long-term effects of hormone replacement therapy - Reply
od: Beral, V, et al.
Izdano: (2003)

Breast cancer and hormone exposure - Reply
od: Beral, V, et al.
Izdano: (1996)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
od: Beral, V, et al.
Izdano: (1997)

Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study.
od: Benson, V, et al.
Izdano: (2010)

False alarm: postmenopausal hormone therapy and ovarian cancer - Response
od: Beral, V, et al.
Izdano: (2007)

Impact of hormone replacement therapy on breast cancer
od: Gathani, T, et al.
Izdano: (2010)

Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia REPLY
od: Canfell, K, et al.
Izdano: (2009)

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study
od: Liu, B, et al.
Izdano: (2008)

Gene-Environment Interactions in 7610 Women With Breast Cancer: Prospective Evidence From the Million Women Study
od: Travis, R, et al.
Izdano: (2010)

GENE-ENVIRONMENT INTERACTIONS IN 7610 WOMEN WITH BREAST CANCER: PROSPECTIVE EVIDENCE FROM THE MILLION WOMEN STUDY
od: Travis, R, et al.
Izdano: (2010)

Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
od: Banks, E, et al.
Izdano: (2006)

Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study.
od: Banks, E, et al.
Izdano: (2004)

Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.
od: Million Women Study Collaborators
Izdano: (2002)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
od: Beral, V, et al.
Izdano: (2004)

CHILDHOOD ADIPOSITY AND BREAST CANCER INCIDENCE IN WOMEN IN MIDDLE AGE
od: Cairns, B, et al.
Izdano: (2010)

Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
od: Beral, V, et al.
Izdano: (2005)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
od: Beral, V
Izdano: (1997)

Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia.
od: Canfell, K, et al.
Izdano: (2008)

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
od: Beral, V, et al.
Izdano: (2011)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens (multiple letters) [13]
od: Beral, V, et al.
Izdano: (1997)

Hormone replacement therapy and ovarian cancer.
od: Beral, V, et al.
Izdano: (1991)

HORMONE REPLACEMENT THERAPY AND OVARIAN-CANCER
od: Beral, V, et al.
Izdano: (1991)

Evidence from randomised trials on the long-term effects of hormone replacement therapy.
od: Beral, V, et al.
Izdano: (2002)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
od: Beral, V, et al.
Izdano: (1997)

Breast cancer and breastfeeding - Reply
od: Beral, V, et al.
Izdano: (2003)

Menopausal hormone therapy and 20-year breast cancer mortality
od: Beral, V, et al.
Izdano: (2019)

Hormone replacement therapy for secondary prevention of coronary heart disease.
od: Banks, E, et al.
Izdano: (1999)

Hormone replacement therapy for secondary prevention of coronary heart disease
od: Banks, E, et al.
Izdano: (1999)

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
od: Reeves, G, et al.
Izdano: (2006)

Variations in the Prevalence of Risk Factors for Breast Cancer in Different Ethnic Groups in the Million Women Study
od: Gathani, T, et al.
Izdano: (2012)

Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
od: Travis, R, et al.
Izdano: (2010)